Literature DB >> 36115898

Medical decision-making competence regarding puberty suppression: perceptions of transgender adolescents, their parents and clinicians.

Lieke Josephina Jeanne Johanna Vrouenraets1,2, Annelou L C de Vries3,4, Marijn Arnoldussen4, Sabine E Hannema5,6, Ramón J L Lindauer7, Martine C de Vries8,6, Irma M Hein7.   

Abstract

According to international transgender care guidelines, transgender adolescents should have medical decision-making competence (MDC) to start puberty suppression (PS) and halt endogenous pubertal development. However, MDC is a debated concept in adolescent transgender care and little is known about the transgender adolescents', their parents', and clinicians' perspectives on this. Increasing our understanding of these perspectives can improve transgender adolescent care. A qualitative interview study with adolescents attending two Dutch gender identity clinics (eight transgender adolescents who proceeded to gender-affirming hormones after PS, and six adolescents who discontinued PS) and 12 of their parents, and focus groups with ten clinicians was conducted. From thematic analysis, three themes emerged regarding transgender adolescents' MDC to start PS: (1) challenges when assessing MDC, (2) aspects that are considered when assessing MDC, and (3) MDC's relevance. The four criteria one needs to fulfill to have MDC-understanding, appreciating, reasoning, communicating a choice-were all, to a greater or lesser extent, mentioned by most participants, just as MDC being relative to a specific decision and context. Interestingly, most adolescents, parents and clinicians find understanding and appreciating PS and its consequences important for MDC. Nevertheless, most state that the adolescents did not fully understand and appreciate PS and its consequences, but were nonetheless able to decide about PS. Parents' support of their child was considered essential in the decision-making process. Clinicians find MDC difficult to assess and put into practice in a uniform way. Dissemination of knowledge about MDC to start PS would help to adequately support adolescents, parents and clinicians in the decision-making process.
© 2022. The Author(s).

Entities:  

Keywords:  Adolescents; Gender dysphoria; Gender incongruence; Medical decision-making competence; Puberty suppression; Qualitative study

Year:  2022        PMID: 36115898     DOI: 10.1007/s00787-022-02076-6

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   5.349


  65 in total

1.  Letter to the Editor: "Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline".

Authors:  Michael K Laidlaw; Quentin L Van Meter; Paul W Hruz; Andre Van Mol; William J Malone
Journal:  J Clin Endocrinol Metab       Date:  2019-03-01       Impact factor: 5.958

Review 2.  Suicidal behaviour among sexual-minority youth: a review of the role of acceptance and support.

Authors:  Vita Poštuvan; Tina Podlogar; Nuša Zadravec Šedivy; Diego De Leo
Journal:  Lancet Child Adolesc Health       Date:  2019-01-22

3.  Early Medical Treatment of Children and Adolescents With Gender Dysphoria: An Empirical Ethical Study.

Authors:  Lieke Josephina Jeanne Johanna Vrouenraets; A Miranda Fredriks; Sabine E Hannema; Peggy T Cohen-Kettenis; Martine C de Vries
Journal:  J Adolesc Health       Date:  2015-06-25       Impact factor: 5.012

4.  Long-term follow-up of transsexual persons undergoing sex reassignment surgery: cohort study in Sweden.

Authors:  Cecilia Dhejne; Paul Lichtenstein; Marcus Boman; Anna L V Johansson; Niklas Långström; Mikael Landén
Journal:  PLoS One       Date:  2011-02-22       Impact factor: 3.240

5.  Trends in suicide death risk in transgender people: results from the Amsterdam Cohort of Gender Dysphoria study (1972-2017).

Authors:  C M Wiepjes; M den Heijer; M A Bremmer; N M Nota; C J M de Blok; B J G Coumou; T D Steensma
Journal:  Acta Psychiatr Scand       Date:  2020-03-12       Impact factor: 6.392

6.  Re-evaluation of the Dutch approach: are recently referred transgender youth different compared to earlier referrals?

Authors:  Marijn Arnoldussen; Thomas D Steensma; Arne Popma; Anna I R van der Miesen; Jos W R Twisk; Annelou L C de Vries
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-08-31       Impact factor: 4.785

7.  Consensus Parameter: Research Methodologies to Evaluate Neurodevelopmental Effects of Pubertal Suppression in Transgender Youth.

Authors:  Diane Chen; John F Strang; Victoria D Kolbuck; Stephen M Rosenthal; Kim Wallen; Deborah P Waber; Laurence Steinberg; Cheryl L Sisk; Judith Ross; Tomas Paus; Sven C Mueller; Margaret M McCarthy; Paul E Micevych; Carol L Martin; Baudewijntje P C Kreukels; Lauren Kenworthy; Megan M Herting; Agneta Herlitz; Ira R J Hebold Haraldsen; Ronald Dahl; Eveline A Crone; Gordon J Chelune; Sarah M Burke; Sheri A Berenbaum; Adriene M Beltz; Julie Bakker; Lise Eliot; Eric Vilain; Gregory L Wallace; Eric E Nelson; Robert Garofalo
Journal:  Transgend Health       Date:  2020-12-11

8.  Perceptions of Sex, Gender, and Puberty Suppression: A Qualitative Analysis of Transgender Youth.

Authors:  Lieke Josephina Jeanne Johanna Vrouenraets; A Miranda Fredriks; Sabine E Hannema; Peggy T Cohen-Kettenis; Martine C de Vries
Journal:  Arch Sex Behav       Date:  2016-06-01

9.  Trajectories of Adolescents Treated with Gonadotropin-Releasing Hormone Analogues for Gender Dysphoria.

Authors:  Tessa Brik; Lieke J J J Vrouenraets; Martine C de Vries; Sabine E Hannema
Journal:  Arch Sex Behav       Date:  2020-03-09
View more
  1 in total

1.  How to deal with moral challenges around the decision-making competence in transgender adolescent care? Development of an ethics support tool.

Authors:  Bert Molewijk; Irma Hein; Janine de Snoo-Trimp; Annelou de Vries
Journal:  BMC Med Ethics       Date:  2022-09-22       Impact factor: 2.834

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.